Takashi Ozaki

Takashi Ozaki

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2010 in The Journal of the Japanese Society of Clinical Cytology
Verified
Journal Article
Closed access
PDF file
ETEmiko Taniguchi
Emiko Taniguchi
JTJyunta Takamatsu
Jyunta Takamatsu
CMChie Marui
Chie Marui
TKTomoko Kagiya
Tomoko Kagiya
ONOsamu Nunobiki
Osamu Nunobiki
Kenichi KakudoKenichi Kakudo
Kenichi Kakudo
目的 : 甲状腺穿刺吸引細胞診で, 良悪性鑑別困難とした症例の精度管理を行った. 濾胞性腫瘍と診断した症例の細胞像を検討し, 悪性の可能性の乏しい腺腫様甲状腺腫を推定する群を抽出した. 方法 : 良悪性鑑別困難の細胞診断の下, 手術された 14 例の細胞所見を再検討し, 組織診断と比較した. 対比症例として濾胞腺腫, 濾胞癌微小浸潤型と比較した. 成績 : 細胞診鑑別困難の手術例 14 例の, 術後の病理診断は, 悪性リンパ腫 5 例, 乳頭癌 1 例, 腺腫様甲状腺腫 6 例, 濾胞腺腫 2 例 (好酸性細胞腺腫 1 例, 異型腺腫 1 例) であった. つまり, 鑑別困難濾胞性腫瘍と診断した 8 例中 6 例 (75%) が腺腫様甲状腺腫 (腺腫結節) であった. これら 8 例の細胞所見の特徴は背景に泡沫細胞や多量のコロイドを認めるなどの嚢胞変性やコロイド嚢胞の特徴がなく, 細胞量も多く腫瘍性と診断したが, さらに(1)濾胞上皮細胞集塊は小型で, N/C 比も比較的大きい (核密度が高い) 群と, (2)細胞集塊は小型で, 細胞の N/C 比も小さい群と, (3)N/C 比が小で, 大型の濾胞細胞集塊が多数みられる 3 群に細分類が可能であった. 結論 : 濾胞性腫瘍と細胞診断した例は 3 群に分割が可能であった. N/C 比の小さい症例で, 細胞量が多くとも, 大型から中型の濾胞上皮集塊のときは, 腺腫様甲状腺腫の可能性が高く, 以降良性と診断することに変更した. 一方, 小型の濾胞細胞集塊が中心の症例では, 悪性の含まれる可能性がある, 真の良悪性鑑別困難であり, N/C 比の小のものは, 良悪性鑑別困難の (A) と診断し, N/C 比が大の (核密度が高い) 症例は, 悪性の含まれる可能性が高い良悪性鑑別困難の (B) と診断する.

1 January 2002 in The Journal of the Japanese Society of Clinical Cytology
Verified
Journal Article
Open access
PDF file
TKTomoko Kagiya
Tomoko Kagiya
ETEmiko Taniguchi
Emiko Taniguchi
ONOsamu Nunobiki
Osamu Nunobiki
IMIchiro Mori
Ichiro Mori
TOTakashi Ozaki
Takashi Ozaki
TSTakeo Sakurai
Takeo Sakurai
背景:術前の穿刺吸引細胞診で, 腫瘍細胞が孤立散在性に出現した乳腺乳管内乳頭腫の1例を経験したので報告する. 症例:患者は40歳女性. 左乳房B領域に直径1cmの嚢胞性腫瘤が認められた. 穿刺吸引細胞診は疑陽性であったため生検が施行された. 細胞診では, 採取された細胞量は多く, ほとんど孤立散在性に出現していた. 細胞質広く, 赤色顆粒を有する大型細胞, 紡錘形細胞, N/C比高く, 核濃染性の小円形細胞など, 多種多様な細胞像であった. 免疫細胞化学的に, 大型細胞はEMA陽性, 小円形細胞等はa smooth muscle actin (a-SMA) 陽性であった. 組織像では, 拡張した乳管の中に乳管内乳頭腫が多量の凝固壊死巣と連続してみられた. 出血梗塞を合併した乳管内乳頭腫と診断された. 結論:乳管内乳頭腫の細胞診では, 乳頭状集を形成するのが一般的特色である. しかし, 出血性梗塞を起こしたときには孤立散在性細胞が出現し, 癌と紛らわしいことがある.

16 November 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
NMNaoki Matsuda
Naoki Matsuda
YYYuichi Yoshida
Yuichi Yoshida
KGKoro Gotoh
Koro Gotoh
SNSatoshi Nagai
Satoshi Nagai
RKRyo Kurimoto
Ryo Kurimoto
HSHirotaka Shibata
Hirotaka Shibata
Background/Objectives: Sleeve gastrectomy (SG) is the most commonly performed bariatric surgery worldwide. It results in significant weight loss and improves metabolic disorders such as hypertension. Weight loss is thought to be the main factor contributing to blood pressure (BP) reduction after SG. Small-intestinal hormones may also mediate the antihypertensive effects of SG. We aimed to investigate the mechanisms underlying the antihypertensive effects of SG through small-intestinal hormones independently of weight loss. Methods: This study involved male Sprague–Dawley rats that underwent a sham operation or SG, followed by a dietary intervention involving a standard diet, a high-fat and high-salt diet, or pair-feeding with SG. Results: Three weeks postoperatively, SG significantly reduced systolic blood pressure (SBP) and increased urinary sodium excretion. RNA sequencing of the small intestine revealed upregulation of the gene encoding prouroguanylin (proUGN). proUGN is a small-intestinal hormone that inhibits renal sodium reabsorption by converting sodium/hydrogen ion exchanger type 3 (NHE3) in the proximal tubules into the inactive phosphorylated form at Ser552 (pS552-NHE3). Furthermore, SG significantly increased proUGN levels in the ileum and plasma, as well as the levels of pS552-NHE3 in the renal cortex. The administration of exogenous uroguanylin, which is converted from proUGN, resulted in increased renal pS552-NHE3, increased urinary sodium excretion, and decreased SBP without body weight reduction. These effects were similar to those observed with SG. Conclusions: SG increases proUGN secretion from the small intestine, leading to increased blood concentration. This inhibits NHE3 activity in the proximal tubules, promotes natriuresis and reduces BP.

Verified
Journal Article
Open access
PDF file
TNTakaaki Noguchi
Takaaki Noguchi
YYYuichi Yoshida
Yuichi Yoshida
KGKoro Gotoh
Koro Gotoh
SNSatoshi Nagai
Satoshi Nagai
KSKentaro Sada
Kentaro Sada
HSHirotaka Shibata
Hirotaka Shibata
A high-fat diet (HFD) can lead to obesity and skeletal muscle atrophy. Sleeve gastrectomy (SG) improves obesity and increases skeletal muscle mass. This study examined whether SG prevented skeletal muscle atrophy in a diet-induced rat obesity rat model. First, 8-week-old male Sprague-Dawley rats underwent surgical (sham-operated or SG) and dietary (standard, high-fat diet, or same pair feeding as SG [PF]) interventions without exercise. In the second experiment, treadmill exercise was added for 4 weeks post-SG (SG + Ex). In the third experiment, rats received an adiponectin receptor agonist (AdipoRon) injection. The HFD induced weight gain and decreased muscle fiber area. SG + Ex reversed these levels, followed by increases in adiponectin in the blood and skeletal muscle and myoblast determination protein 1 (MyoD) and decreased peri-muscular adipose tissue (PMAT) mass, but SG alone did not. No similar changes were observed in the PF group, with or without exercise. Injection of AdipoRon had a similar effect on skeletal muscle and PMAT as SG + Ex. The combination of SG and exercise, but not calorie restriction alone, had better impacts on skeletal muscle and PMAT than SG or exercise alone.

1 December 2011 in European Surgical Research
Verified
Journal Article
Open access
PDF file
TMTakahiro Mukai
Takahiro Mukai
SKShigeki Kamitani
Shigeki Kamitani
TST. Shimizu
T. Shimizu
MFM. Fujino
M. Fujino
YTY. Tsutamoto
Y. Tsutamoto
DBDruck Reinhardt Druck Basel
Druck Reinhardt Druck Basel

1 May 2018 in International Surgery
Verified
Journal Article
Open access
KIKentaro Inoue
Kentaro Inoue
TMTaku Michiura
Taku Michiura
JFJunichi Fukui
Junichi Fukui
HMHiromi Mukaide
Hiromi Mukaide
TOTakashi Ozaki
Takashi Ozaki
MHMadoka Hamada
Madoka Hamada
Objective: The aim of this study was to compare the scar quality associated with different types of subcuticular suture techniques: running or interrupted. Summary of Background Data: Subcuticular suture is a preferred skin closure method even in gastrointestinal surgery. Two methods for subcuticular suture are used: running or interrupted sutures. Methods: Inclusion criteria were as follows: age ≥ 20 years; American Society of Anesthesiologists performance status 1 to 3; histologically proven adenocarcinoma of the stomach; no evidence of distant metastases or disease considered unresectable; no prior upper abdominal surgery; no uncontrolled infections, diabetes, or cardiac disease; and adequate renal function. Patients were randomly assigned to running subcuticular suture or interrupted subcuticular suture. Scar areas were calculated using a digital photograph calculator at about 7 months after surgery. The observer scar assessment scale (OSAS) was used for scar assessment. Results: Between April 10, 2009, and February 28, 2012, 220 patients were enrolled into this study and 201 patients were evaluated. There was no difference in scar area between the interrupted group and the running group [0.97 cm2 (95% CI: 0.73–1.21) in the interrupted group and 1.17 cm2 (95% CI: 0.91–1.42, P = 0.27) in the running group]. Three observers performed the OSAS, for which no significant difference was detected across the closure groups. Conclusions: There were no significant differences in cosmetic outcomes between running and interrupted subcuticular sutures. The final decision about the choice of method should be made balancing surgeon needs (time-saving with running) and surgeon techniques (running might be difficult).